Express Scripts Holding Company company logo

# 1st Gen Model Express Scripts Holding Company Drug stores & proprietary stores

66.15% successful of 65 deals
$69.02 Last close price
at 14-dec-2017


Model's trade recommendations -1.22% Return for period

4.62% Annual return

$38.84B Market Cap

β 0.88  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period -1.22%
52wk return 2.63%
52wk Range
Sortino ratio 0.75
Sharpe ratio 0.55
Norm. RMSE 0.58%
Downside risk 6.02%
Volatility 8.27%
  • BUY Analysts consensus recommendation

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company. It operates in two segments, PBM and Other Business Operations. The PBM segment offers clinical solutions, specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, administration of a group purchasing organization, and consumer health and drug information services. This segment also provides Medicare, Medicaid, health insurance marketplace products etc. The Other Business Operations segment distributes pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides consulting services, such as design, implementation, and project management for pharmaceutical and biotechnology manufacturers to collect scientific evidence to guide the use of medicines.

Industry sector: Medical

Sector classification: Drug stores & proprietary stores

Deep Learning based analysis and prediction model for Express Scripts Holding Company (ESRX) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 23, 2015.

Market data for ESRX model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 563M
P/E 10.02
Shares Outstanding 566M
% Held by Insiders 0.68%
% Held by Institutions 88.44%
EPS (last reported FY) $6.39
EPS (last reported Q) $1.90
EPS, estimated (last reported Q) $1.90
Total revenues $100 B
Net income $3 B